RETRACTED: circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression

Abstract

Keywords

hsa_circ_104566 miR-338-3p FOXP1 HCC progression

At the request of the Journal Editor and Publisher, the following articles have been retracted

Zhang T, Zhang L, Han D, Tursun K, Lu X. Circular RNA hsa_Circ_101141 as a competing endogenous RNA facilitates tumorigenesis of hepatocellular carcinoma by regulating miR-1297/ROCK1 pathway. Cell Transplantation. 2020;29. doi:10.1177/0963689720948016.

Du C, Wang Y, Zhang Y, Zhang J, Zhang L, Li J. LncRNA DLX6-AS1 contributes to epithelial–mesenchymal transition and cisplatin resistance in triple-negative breast cancer via modulating miR-199b-5p/paxillin axis. Cell Transplantation. 2020;29. doi:10.1177/0963689720929983.

Wan Q, Chen Q, Cai D, Zhao Y, Wu X. OTUB2 promotes homologous recombination repair through stimulating Rad51 expression in endometrial cancer. Cell Transplantation. 2020;29. doi:10.1177/0963689720931433.

Li W, Yang X, Shi C, Zhou Z. Hsa_circ_002178 promotes the growth and migration of breast cancer cells and maintains cancer stem-like cell properties through regulating miR-1258/KDM7A axis. Cell Transplantation. 2020;29:. doi:10.1177/0963689720960174.

Liu G, Guo W, Rao M, Qin J, Hu F, Li K. circRNA hsa_circ_104566 sponged miR-338-3p to promote hepatocellular carcinoma progression. Cell Transplantation. 2020;29. doi:10.1177/0963689720963948.

Li J, Yu Z, Zhu Q, Tao C, Xu Q. hsa_circ_102559 acts as the sponge of miR-130a-5p to promote hepatocellular carcinoma progression through regulation of ANXA2. Cell Transplantation. 2020;29. doi:10.1177/0963689720968748.

Li J, Yang Y, Xu D, Cao L. hsa_circ_0023409 accelerates gastric cancer cell growth and metastasis through regulating the IRS4/PI3K/AKT pathway. Cell Transplantation. 2021;30. doi:10.1177/0963689720975390.

Wang Y, Yin L. LINC00461 promoted endometrial carcinoma growth and migration by targeting MicroRNA-219-5p/cyclooxygenase-2 signaling axis. Cell Transplantation. 2021;30. doi:10.1177/0963689721989616.

Wu J, Wang X, Yuan X, et al. Kinesin family member C1 increases temozolomide resistance of glioblastoma through promoting DNA damage repair. Cell Transplantation. 2021;30. doi:10.1177/0963689721991466.

Hui Y, Yang Y, Li D, et al. LncRNA FEZF1-AS1 modulates cancer stem cell properties of human gastric cancer through miR-363-3p/HMGA2. Cell Transplantation. 2020;29. doi:10.1177/0963689720925059.

After an internal investigation, Sage has become aware that the submissions contain indicators of third-party involvement. Due to concerns around author contributions to the articles, as well as concerns around the integrity of the research process, Sage and the Journal Editor retract the articles.

The authors have been informed of this decision using the email addresses provided at submission.

References

Ziogas

Tsoulfas

. Advances and challenges in laparoscopic surgery in the management of hepatocellular carcinoma. World J Gastrointest Surg. 2017;9(12):233–245.

Ruzic

Pellicano

Fabri

Luzza

Boccuto

Brkic

Abenavoli

. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review. Panminerva Med. 2018;60(4):185–191.

Petruzziello

. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) related hepatocellular carcinoma. Open Virol J. 2018;12:26–32.

Cao

Quanlin

Assaraf

Xiangdong

. Retinoids offer new and promising cancer therapeutic avenues. J Mol Clin Med. 2019;2(2):23–28.

Jeck

Sharpless

. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–461.

You

Vlatkovic

Babic

Will

Epstein

Tushev

Akbalik

Wang

Glock

Quedenau

Wang

, et al. Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity. Nat Neurosci. 2015;18(4):603–610.

Yang

Zhu

. Circular RNAs: from biogenesis and function to diseases. Chin Med J (Engl). 2019;132(20):2457–2464.

Qiu

Wang

Tang

Chen

. Circular RNA signature in hepatocellular carcinoma. J Cancer. 2019;10(15):3361–3372.

Qin

Liu

Huo

Tao

Sun

Yang

Fan

Liu

Qin

. Hsa_circ_0001649: a circular RNA and potential novel biomarker for hepatocellular carcinoma. Cancer Biomark. 2016;16(1):161–169.

10.

Zhang

Zheng

Lan

. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2016;143(1):17–27.

11.

Yao

Luo

Lin

Huang

Wang

Zhang

Xiong

Huang

Liu

, et al. ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways. Mol Oncol. 2017;11(4):422–437.

12.

Shao

Yang

Xiao

Guo

. Global circular RNA expression profile of human gastric cancer and its clinical significance. Cancer Med. 2017;6(6):1173–1180.

13.

Peng

Shi

Zhang

Wang

. Microarray profiling of circular RNAs in human papillary thyroid carcinoma. PLoS One. 2017;12(3):e0170287.

14.

Jin

Wang

Pang

Zhou

Liang

Yang

Zhang

. Upregulated hsa_circ_0004458 contributes to progression of papillary thyroid carcinoma by inhibition of miR-885-5p and activation of RAC1. Med Sci Monit. 2018;24:5488–5500.

15.

Conn

Pillman

Toubia

Conn

Salmanidis

Phillips

Roslan

Schreiber

Gregory

Goodall

. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125–1134.

16.

Ambros

. The function of animal MicroRNAs. Nature. 2004;431(7006):350–355.

17.

Balogh

Victor

3rd Asham

Burroughs

Boktour

Saharia

Ghobrial

Monsour

Jr . Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016;3:41–53.

18.

Yin

Long

Liao

Zhu

. Emerging roles of circRNA in formation and progression of cancer. J Cancer. 2019;10(21):5015–5021.

19.

Dai

Chen

Wei

Zhu

Lan

Dai

Qin

. Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma. Oncotarget. 2017;8(56):95799–95809.

20.

Wang

Long

Zheng

Xiao

. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol Cancer. 2019;18(1):119.

21.

Liu

. Circular RNA hsa_circ_0001649 inhibits hepatocellular carcinoma progression via multiple miRNAs sponge. Aging (Albany NY). 2019;11(10):3362–3375.

22.

Wang

Shi

Liu

. Immunohistochemical detection of proliferating cell nuclear antigen in hepatocellular carcinoma. World J Gastroenterol. 1997;3(2):101–103.

23.

Yuen

M-F

P-C

Lai

VC-H

Lau

JY-N

Lai

C-L

. Expression of c-Myc, c-Fos, and c-Jun in hepatocellular carcinoma. Cancer. 2001;91(1):106–112.

24.

Zhang

Liu

Zhu

. Chrysin induces cell apoptosis via activation of the p53/Bcl-2/caspase-9 pathway in hepatocellular carcinoma cells. Exp Ther Med. 2016;12(1):469–474.

25.

van Zijl

Zulehner

Petz

Schneller

Kornauth

Hau

Machat

Grubinger

Huber

Mikulits

. Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol. 2009;5(8):1169–1179.

26.

Huang

Wang

Chen

Zhang

Zeng

, et al. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res. 2009;39(8):786–794.

27.

Zhang

Liu

Zeng

Jiang

Guo

Zhang

Chen

. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma. Biomed Pharmacother. 2016;84:583–591.

28.

Huang

Chen

Wang

Chen

Wen

Chen

Zhang

Zeng

. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol. 2011;225(3):463–472.

29.

Chen

Liang

Chen

Shen

Chen

Zhang

Zeng

, et al. miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells. Oncotarget. 2017;8(42):71418–71429.

30.

Zhao

Fang

Sun

Zhang

Zhan

Liu

Zhang

. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α. PloS One. 2014;9(12):e115565–e115565.

31.

Zheng

Luo

Zeng

Guo

Shao

. 125I suppressed the Warburg effect viaregulating miR-338/PFKL axis in hepatocellular carcinoma. Biomed Pharmacother. 2019;119:109402.

32.

Nie

Yang

X-M

Cao

Q-Z

Feng

M-X

Xue

Wei

Qin

Xia

Zhang

Z-G

. Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma. Hepatology. 2015;62(4):1145–1159.

33.

Zhang

Wang

Liu

Yang

Chen

Huang

. Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma. J Clin Pathol. 2012;65(6):528.

34.

Wang

Sun

Cui

Zhao

Chen

Yao

. Downregulation of FOXP1 inhibits cell proliferation in hepatocellular carcinoma by inducing G1/S phase cell cycle arrest. Int J Mol Sci. 2016;17(9):1501.

35.

Shen

Zheng

Fan

. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics. 2019;11(1):25.

36.

Wang

Long

Luo

Wei

. hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p. J Cell Mol Med. Epub ahead of print 2020.

37.

Wang

Sun

. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). Int J Clin Exp Pathol. 2015;8(1):337–344.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.07 MB